ANGELIQ Drug Profile, 2020

$499.00

ANGELIQ Drug Profile, 2020

This report focuses on ANGELIQ and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
SKU: 021355 Category:

Description

Copyright © DrugPatentWatch. Originally published at ANGELIQ Drug Profile, 2020

ANGELIQ Drug Profile, 2020

This report focuses on ANGELIQ and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers

Contents

  • Profile for ANGELIQ
  • US Patents
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Finished Product Suppliers

    Make Better Decisions with DrugPatentWatch

    Try a trial or schedule a demo

    Copyright © DrugPatentWatch. Originally published at ANGELIQ Drug Profile, 2020